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ABSTRACT
Unconventional mRNA splicing by an endoplasmic reticulum stress-inducible endoribonuclease, IRE1, is conserved in all known
eukaryotes. It controls the expression of a transcription factor, Hac1p/XBP-1, that regulates gene expression in the unfolded
protein response. In yeast, the RNA fragments generated by Ire1p are ligated by tRNA ligase (Trl1p) in a process that leaves a
29-PO4
2 at the splice junction, which is subsequently removed by an essential 29-phosphotransferase, Tpt1p. However,
animals, unlike yeast, have two RNA ligation/repair pathways that could potentially rejoin the cleaved Xbp-1 mRNA fragments.
We report that inactivation of the Trpt1 gene, encoding the only known mammalian homolog of Tpt1p, eliminates all detectable
29-phosphotransferase activity from cultured mouse cells but has no measurable effect on spliced Xbp-1 translation.
Furthermore, the relative translation rates of tyrosine-rich proteins is unaffected by the Trpt1 genotype, suggesting that the
pool of (normally spliced) tRNATyr is fully functional in the Trpt1/ mouse cells. These observations argue against the
presence of a 29-PO4
2 at the splice junction of ligated RNA molecules in Trpt1/ cells, and suggest that Xbp-1 and tRNA
ligation proceed by distinct pathways in yeast and mammals.
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INTRODUCTION
Eukaryotic cells respond to the stress of protein misfolding
in the endoplasmic reticulum by a signal transduction
pathway that culminates in enhanced transcription of genes
encoding ER chaperones (for review, see Ron and Walter
2007). In yeast, this unfolded protein response (UPR) is
initiated by the ER stress-induced activation of an endo-
ribonuclease, Ire1p, that excises an internal inhibitory
fragment of the HAC1 mRNA (Cox and Walter 1996; Mori
et al. 1996). The two ends of the mRNA are joined together
by Trl1p, the same enzyme that ligates endonucleolytically
processed pre-tRNAs in tRNA splicing (Sidrauski et al.
1996). Unlike its precursor, the spliced HAC1 mRNA is
efficiently translated into a transcription factor that activates
genes encoding ER chaperones (Ruegsegger et al. 2001).
RNA ligation by Trl1p entails three distinct steps:
hydrolysis of the 29-39-cyclic phosphate bond at the end
of the 59-RNA fragment, phosphorylation of the 59-
hydroxyl of the 39-fragment (with GTP as a phosphate
donor), and the joining together of the two ends in a
ligation step involving an adenylated intermediate (reviewed
in Abelson et al. 1998; Hopper and Phizicky 2003). These
three steps leave a 29-phosphate (29-PO4
2) at the 59-splice
junction, which in yeast is removed by a 29-phosphotrans-
ferase Tpt1p, encoded by an essential gene TPT1 (Culver
et al. 1997). Tpt1p is an unusual enzyme that utilizes NAD+
as a cosubstrate in a reaction that generates a 29 hydroxyl
(restoring the RNA to its conventional structure), nicotin-
amide, and ADP-ribose 100-200 cyclic phosphate (Appr>p)
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(Culver et al. 1993). Genetic and biochemical studies have
shown that removal of the residual 29-PO4
2 from ligated
RNAs is the only essential function of yeast TPT1 (Schwer
et al. 2004), and that Ire1p-induced HAC1 mRNA splicing
entails all the enzymatic steps described above (Gonzalez
et al. 1999).
IRE1 is conserved in other eukaryotes (Tirasophon et al.
1998; Wang et al. 1998), as is its function to cleave a
preexisting mRNA in ER stressed cells (Yoshida et al. 2001;
Calfon et al. 2002). Likewise conserved is the ligation of
the cleaved fragments of the mRNA to generate a spliced
version encoding a transcription factor (XBP-1 in meta-
zoans) that activates target genes of the UPR (Yoshida et al.
2001; Calfon et al. 2002; Lee et al. 2005). Despite conser-
vation between yeasts and animals of both the biochemistry
of IRE1 action and its biological consequences, the ligase
mediating Xbp-1 mRNA splicing in animals remains
unknown.
Study of a related process, the ligation of spliced pre-
tRNA halves, has suggested the presence of two alternative
enzymatic pathways for attaining this goal in animal cells.
The first, homologous to the yeast
pathway, uses the g-phosphate of ATP
to form the phosphodiester bond that
reunites the RNA fragments and leaves
a 29-PO4
2 at the 59-splice junction
(Zillmann et al. 1991). A second enzy-
matic pathway in mammalian cells has
no apparent counterpart in yeast. It
rejoins the tRNA halves using the orig-
inal phosphate that was left at the 39-
end of the 59-tRNA fragment by the
endoribonuclease (Standring et al. 1981;
Filipowicz and Shatkin 1983; Laski et al.
1983) similar to the pathway used by
archaea to splice tRNAs (Zofallova et al.
2000; Salgia et al. 2003). The yeast-like
pathway is presumed to require the
removal of the 29-PO4
2, as the latter’s
retention in yeast lacking TPT1 inter-
feres with tRNA maturation (Spinelli
et al. 1997), whereas the archaeal-like
pathway is unlikely to share this
requirement.
Mammalian genomes encode a single
known functional homolog of yeast
Tpt1p (Zillmann et al. 1991; Spinelli
et al. 1998) encoded by Trpt1 (Hu et al.
2003). To gain further insight into the
role of 29-PO4
2 removal in Xbp-1
splicing, we inactivated the Trpt1 gene
in mouse. Despite lack of detectable in
vitro RNA 29-phosphotransferase activ-
ity in lysates of cells derived from the
Trpt1 knockout mice, there was no
evidence for a defect in the UPR or in tRNA function.
These findings provide new clues to the mechanism of RNA
ligation in mammals.
RESULTS AND DISCUSSION
The Trpt1 gene was disrupted by homologous recombina-
tion in ES cells, deleting exons 3, 4, and part of exon 5 that
encode amino acids 48–173 (Fig. 1A). The deletion
encompasses residues whose counterparts in yeast Tpt1p
are essential for enzymatic activity (Sawaya et al. 2005;
Steiger et al. 2005) and the mutant allele likely functions as
a null. The mutation was transmitted through the germline
of chimeric mice. Surprisingly, Trpt1/ descendents were
recovered from mating of heterozygous parents at the
z25% frequency (expected of a nonlethal mutation; Fig.
1B) and the mutant mice appeared healthy and were
normally fertile (data not shown).
Immunoprecipitation of TRPT1 from heart lysates, an
abundant source of the enzyme (Hu et al. 2003), followed
by immunoblot with an antiserum raised to bacterially
FIGURE 1. Trpt1/ mice are viable. (A) Schema of the mouse Trpt1 genomic locus, the
targeting vector used to disrupt the gene and the structure of the Trpt1/ mutant allele. The
floxed pGK-Neo cassette was inserted in a direction opposite to that of Trpt1 replacing exons
3, 4, and part of 5. Primers used for genotyping wild-type and Trpt1 mutant alleles are in-
dicated by arrows. (B) Graph of the percent of each genotype obtained in matings of Trpt1+/
mice. N = 39. (C) Immunoblot of proteins immunopurified with anti-TRPT1 antiserum from
extracts of heart tissue from Trpt1 +/+, +/, or / mice. The loading control represents a
nonspecific protein that copurifies with the TRPT1 antibody.
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expressed murine TRPT1 revealed that Trpt1/ mice lack
detectable protein and heterozygotes express z50% of
wild-type levels (Fig. 1C). These results indicate that unlike
its yeast homolog, an essential enzyme (Culver et al. 1997),
Trpt1 is dispensable for survival of mammalian cells under
normal circumstances.
Trpt1 is the only source of detectable
29-phosphotransferase activity in mouse cells
To determine if dispensability of Trpt1
reflects dispensability of 29-phospho-
transferase activity, we sought to com-
pare this enzymatic activity in lysates of
wild-type cells and Trpt1/ cells using
a modification of an established assay in
which it was shown that partially puri-
fied HeLa 29-phosphotransferase specif-
ically removes 29-phosphates from both
ligated tRNAs and RNA substrates as
small as di-nucleotides (Zillmann et al.
1992). Mouse embryo fibroblasts were
procured from wild-type and Trpt1/
embryos, and immunoblotting con-
firmed the absence of TRPT1 protein
in the latter (Fig. 2A). Two homouridylic
pentamer substrates without (U5) or
with a 29-PO4
2 (U5P) at nucleotide
position 3 were synthesized and 59-end
labeled with polynucleotide kinase
and [g32P]ATP. Consistent with the
two negative charges provided by the
29-PO4
2, U5P had greater mobility
than U5 in denaturing PAGE due to a
smaller mass charge ratio (m/z) (Fig.
2B, cf. lanes 2 and 5). This provided a
criterion for distinguishing RNA mole-
cules that have or lack a 29-PO4
2.
Incubation with pure, bacterially ex-
pressed yeast Tpt1p (yTpt1p) converted
the faster migrating, U5P to a species of
slower mobility, which comigrated with
the U5 reference probe (that lacks a 29-
PO4
2) (Fig. 2B, lanes 4,5). This con-
version was dependent on addition of
NAD+ to the reaction, and is consistent
with the known dependence of Tpt1p’s
29-phosphotransferease activity on NAD+
as a cosubstrate. Appr>p and nicotin-
amide (products predicted by the reac-
tion) remain undetected, as they are
unlabeled and yTpt1p had no effect on
the mobility of the U5 probe, as predicted
(Fig. 2B, lane 1). These observations
validated radiolabeled U5P as a substrate for Tpt1p/TRPT1’s
29-phosphotransferease activity in this simple assay.
Extracts of Trpt1+/+ cells had measurable NAD+-depen-
dent 29-phosphotransferase activity, reflected in conversion
of the faster migrating U5P probe to the slower migrating
U5 species (Fig. 2B, lanes 9,13), whereas lysate of Trpt1/
cells lacked detectable 29-phosphotransferase activity (Fig.
2B, lanes 7,11). The faster migrating species generated in
some reactions (Fig. 2B, marked with an asterisks) likely
represents cleavage of the probe by a contaminating
FIGURE 2. Trpt1/ cell extracts lack 29-phosphotransferase activity. (A) Anti-TRPT1
immunoblot of proteins immunopurified from Trpt1+/+ or Trpt1/ cells. (B) Autoradio-
graph of 59-32PO4
2-labeled RNA substrates consisting of five uridines (U5) or five uridines
with a 29-PO4
2 on the third base (U5P) that have been incubated in the absence () or
presence of purified yeast Tpt1p (Y) or 32 ng or 80 ng protein from whole cell extracts (WCE)
from Trpt+/+ (W) or Trpt1/ (T) cells with or without NAD+. Migration of the radiolabeled
U5 and U5P probes and that of a degradation product (*) is marked to the left of the
autoradiogram. (C) Autoradiograph of 29-phosphotransferase reaction products from sub-
strates incubated with yTpt1p (Y); WCE from Trpt+/+ or Trpt1/ (80 ng [WL, TL] or 160 ng
[WH, TH]), or 5 mL of the indicated fraction of proteins separated on a 10%–30% glycerol
gradient. (D) Evaluation of the NAD+ dependence of the 29-phosphotransferase activity from
the peak (fraction 2) of the glycerol gradients shown in panel C.
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nuclease. Appearance of this fast-migrating species upon
incubation of the U5 probe with cell lysate (Fig. 2B, lanes
6,10) and its absence from samples in which the U5P probe
was incubated with lysate but without NAD+ (Fig. 2B, lanes
8,12) argues that a 29-PO4
2 protects the RNA probe from
degradation and suggests that the contaminating nuclease is
a conventional RNase (Zillmann et al. 1991).
To confirm these observations we fractionated proteins
from wild-type and Trpt1/ cells on glycerol gradients
and measured 29-phosphotransferase activity in the various
fractions. Lysates from wild-type cells had a conspicuous
peak of NAD+-dependent 29-phosphotransferase activity in
light fractions (Fig. 2C, fractions 1–3, 2D, lane 4) that was
absent from samples prepared from mutant cells. Much
weaker activity was present in heavier fractions (Fig. 2C,
fractions 8–16), and variable levels of contaminating RNase
activity were also noted (Fig. 2C, fractions 4–7). No activity
was detected in fractions from Trpt1/ lysates. Our
observations are consistent with a previous report demon-
strating a single peak of 29-phosphotransferase activity in
fractionated HeLa extracts (Zillmann et al. 1992) and
indicate that Trpt1/ cells lack an alternative 29-phos-
photransferase detectable by this assay.
Normal translation of spliced XBP-1 mRNA
in ER stressed Trpt1/ cells
Were it to occur by a yeast-like pathway, ligation of IRE1-
cleaved XBP-1 mRNA is predicted to result in (normally
transient) 29 phosphorylation of the splice junction gua-
nosine 832. In Trpt1/ cells the spliced XBP-1 mRNA is
predicted to retain this 29-PO4
2 on guanosine 832, which
is the first codon for alanine 161. High-resolution structure
of the translating small ribosomal subunit reveals hydrogen
bonding between the 29OH of the universally conserved
base (A1492 of the 16S ribosomal RNA) and the 29OH
of the first codon on the mRNA, as the latter base pairs
with the cognate tRNA in the ribosome’s ‘‘A’’ site (Ogle
et al. 2001). Barring an unanticipated major functional
difference between mammalian and bacterial ribosomes,
the disruption of this conserved contact by a 29-PO4
2
on the first codon is predicted to interfere with monitor-
ing codon–anticodon interactions in translation of the
29-phosphorylated spliced XBP-1 mRNA. Therefore, we
examined the consequences of Trpt1 deficiency on XBP-1
expression in ER stressed cultured cells.
The unspliced XBP-1 mRNA encodes a 30-kDa unstable
protein (XBP-1u) that does not accumulate in cells,
whereas the spliced mRNA encodes a 39-kDa protein
(XBP-1p) that is detectable by immunoblot as an anoma-
lously migrating 54-kDa species from nuclear extracts of
stressed cells (Yoshida et al. 2001; Calfon et al. 2002).
Therefore, we compared the level of XBP-1p protein and
other ER stress markers in Trp1+/+ and Trpt1/ cells,
following activation of the unfolded protein response by
tunicamycin or thapsigargin (drugs that cause protein
misfolding in the ER). Trpt1+/+ and Trpt1/ cells
responded similarly and predictably to ER stress, initially
with increased eIF2a phosphorylation that recovers to basal
levels following induction of the eIF2a phosphatase
GADD34. Furthermore, cells from both genotypes induced
XBP-1p and the ER stress responsive target CHOP in
parallel, with only subtle differences in kinetics (Fig. 3A).
FIGURE 3. XBP-1p is expressed Trpt1/ cells. (A) Immunoblot
detection of XBP-1, CHOP, GADD34, phospho-eIF2a, and total
eIF2a from nuclear (upper two panels) or cytoplasmic (lower three
panels) extracts prepared from Trpt1+/+ or Trpt1/ cells treated
with 2 mg/mL tunicamycin (Tm) or 0.5 mM thapsigargin (Tg) for the
indicated period in order to perturb protein folding in the endoplas-
mic reticulum and activate the UPR. (B) Blood glucose levels of
Trpt1+/+ and Trpt1/ mice at the indicated time points following
intraperitoneal injection of 2 mg/kg body weight glucose. (C)
Autoradiograph of XBP-1p, XBP-1u, CREB, and eIF2a immunopuri-
fied from Trpt1+/+ and Trpt1/ cells that were treated with
thapsigargin for a total of 0, 1, or 6 h and metabolically labeled for
the last hour with 35S-methionine/cysteine in the presence of the
proteosome inhibitor MG132. (D) Quantitation of the 35S-methio-
nine/cysteine incorporation into the proteins shown in panel C.
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These findings indicate that cells of either genotype
experienced similar levels of stress and suggest similar
capability to translate the spliced XBP-1p mRNA.
Glucose homeostasis is sensitive to subtle defects in the
UPR in general and in XBP-1 function in particular, as
hemizygous loss of XBP-1 promotes insulin resistance
(Ozcan et al. 2004). However, glucose tolerance, reflected
in the ability of mice to assimilate a load of injected glu-
cose, was unimpaired in Trpt1/ mice (Fig. 3B), further
arguing against a severe functional defect in XBP-1 expres-
sion in the mutant mice. It is worth noting, however, that
a subtler defect in XBP-1 function may have been missed
by this assay but may be exposed in the future by placing
Trpt1/ mice on a high-fat diet (Ozcan et al. 2004).
To directly compare synthesis rates of XBP-1p and XBP-
1u, Trpt1+/+ and Trpt1/ cells were exposed to thapsi-
gargin in the presence the proteasome inhibitor MG132
(which stabilizes the XBP-1u protein) and the incorpora-
tion of 35S-methionine/cysteine into newly synthesized
proteins was measured by brief pulse-labeling and immu-
noprecipitation. Both forms of XBP-1 and the reference
proteins, CREB and eIF2a, were synthesized at similar rates
in Trpt1+/+ and Trpt1/ cells (Fig. 3C,D), arguing
against significant retention of a 29-PO4
2 at the XBP-1p
mRNA splice junction.
Normal translation of tyrosine-rich proteins
in Trpt1/ cells
Retention of the 29-PO4
2 in spliced yeast tRNAs com-
promises an essential modification of the normally hyper-
modified position one base 39 of the anticodon (Spinelli
et al. 1997). Since all known functional tRNATyr genes in mice
(and humans) contain introns disrupting their anticodon
loops (Lowe and Eddy 1997), the tRNATyr pool is predicted
to be sensitive to defects in tRNA splicing, were they to
occur. The relative incorporation of tyrosine into newly
synthesized proteins was therefore used as a surrogate for
the functional state of the tRNATyr pools in Trpt1+/+ and
Trpt1/ cells.
Whether grown in serum-poor media (which represses
translation) or serum-rich media (which stimulates it),
Trpt+/+ and Trpt1/ cells incorporated 35S-methionine/
cysteine indistinguishably into the tyrosine-rich proteins
EWS, TLS/FUS, and TAF15 (tyrosine content 6.4%, 6.9%,
and 9%, respectively), eIF2a (a protein with average
tyrosine content, 3.8%) and total cellular proteins (Fig.
4A, cf. lanes 1,6 and 3,8, 4B, quantified). Comparison of
incorporation of 3H-tyrosine and 35S-methionine/cysteine
into total proteins confirmed that wild-type and Trpt1/
cells had similar incorporation rates of either amino acid
(Fig. 4C). Together these findings argue against the defect
in the function of spliced tRNATyr that is predicted by the
retention of a 29-PO4
2 at the splice junction, were it to
occur in mutant cells, although it remains formally possible
that both the tRNA charging (tRNAtyr) synthetase and the
mammalian ribosome have evolved to function in presence
of a 29-PO4
2 in the anticodon loop of tRNAs.
CONCLUSIONS
Trpt1/ cells lack detectable in vitro RNA 29-phospho-
transferase activity yet retain the ability to translate spliced
FIGURE 4. Trpt1/ cells incorporate tyrosine into proteins at
normal rates. (A) Autoradiograph of 35S-methionine/cysteine meta-
bolically labeled immunopurified tyrosine-rich proteins TLS/FUS
(6.9% tyrosine), EWS (6.41% tyrosine), and TAF15 (9% tyrosine),
eIF2a (3.8% tyrosine, representing a protein of average tyrosine
content) (Echols et al. 2002) from Trpt+/+ and Trpt1/ cells that
were either untreated, treated with 100 mg/mL cycloheximide for
5 min before and during labeling, or serum starved for 48 h followed
by continued starvation or refeeding for the indicated time prior
to labeling for 1 h prior to harvest (54 h total). The bottom panel
displays 35S-methionine/cysteine incorporation into total protein
from each sample. (B) Quantitation of the radiolabel incorporated
into EWS, TLS, and eIF2a (from A). Quantitation of 3H-tyrosine
and 35S-methionine/cysteine incorporation into TCA precipitable
proteins in Trpt1+/+ and Trpt1/ cells. Mean 6 SEM for triplicate
samples is shown.
Trpt1 and RNA ligation
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XBP-1 mRNA and synthesize tyrosine-containing proteins
at wild-type levels. Barring the existence of an enzymatic
activity that is undetected by our assay, these findings point
directly to the dispensability of 29-phosphotransferase activ-
ity in mice and provide a strong indirect argument against
the presence of a 29-PO4
2 at the splice junction of ligated
XBP-1p and tRNAtyr RNA molecules in animals. Given that
a 29-PO4
2 at the splice junction is a feature of the yeast-like
ligation pathway, the findings presented here are consistent
with that pathway’s dispensability in mammals and suggests
the sufficiency of the archaea like pathway. This conclusion
is further supported by the viability of mouse cells lacking
CNP1 (Lappe-Siefke et al. 2003), the only mammalian
enzyme known to perform the first step in the yeast-like
ligation pathway (hydrolysis of the 29-39-cyclic phosphate
bond at the 59-splice site (Schwer et al. 2007).
The preeminence in mammals of the biochemically
defined archaea-like pathway for RNA end joining that is
suggested by this study is seemingly challenged by the
finding that inactivation of hClp1, a mammalian kinase
that phosphorylates the 59-OH of RNA fragments, reduces
the in vitro tRNA splicing activity of cell lysates (Weitzer
and Martinez 2007). An analysis of hClp1’s role in RNA
ligation in vivo might be informative; however, the inter-
pretation of this data would be challenging because hClp1
has other functions such as promoting mRNA 39-end
formation (Paushkin et al. 2004). Thus, clarity of the
pathways contributing to end joining awaits identification
and mutational analysis of the elusive enzyme(s) catalyzing
the reaction in mammals.
Our phenotypic analysis of the Trpt1/ mice had
focused on the essential aspects of expression of spliced
XBP-1 mRNA and surrogate measures of tRNA processing,
which appear unaffected by the mutation. However, more
subtle defects in these or other processes could easily have
been missed. For example, it might be important to
determine if the Trpt1/ mice phenocopy the Cnp1/
mice and also develop a late-onset neurodegenerative
disorder (Lappe-Siefke et al. 2003). Given that the two
enzymes likely work sequentially in a linear pathway, it
might then be worth inquiring into the possibility of a
hitherto undiscovered signaling role for their product,
Appr>p. These questions are of more than academic
interest: TPT1 and the yeast-like pathway for RNA ligation
are essential in yeast. If, as our study and the accompanying
paper (Schwer et al. 2007) suggest, they might be dispensable
to mammalian health, inhibitors of Tpt1p (and possibly
Trl1p) might prove useful as selective antifungal agents.
MATERIALS AND METHODS
Gene targeting and animal experiments
The murine Trpt1 gene was targeted in E14 ES cells with a
positive–negative selection vector in which a floxed PGKTneor
cassette oriented opposed to transcription of the Trpt1 gene was
used to replace a 1172bp genomic region encompassing exons 3, 4,
and part of exon 5 that encode amino acids 48–173. The
59-homology arm consists of the 3,478bp Ssp1 and XbaI fragment
of the 4253-bp PCR product amplified from ES cell genomic
DNA using primers mTPT1.9S: 59-TACCTGTCAGGCTGACTTCT
CAGTAGCCTGG-39 and mTPT1.8AS: 59-TGCTTTTCGTTGGTA
TTGACCACGAGCTGCAC-39. The 39-homology arm consists of
the 5409-bp ClaI and XbaI fragment of the 6176-bp PCR product




Clones from two individually selected heterozygous ES cell lines
were injected into blastocysts and the resultant founder chimeras
bred to obtain two lines of Trpt1+/ and Trpt1/ mice that
were both viable and healthy. Line 1D1 was used in subsequent
studies to obtain tissue and mouse embryonic fibroblasts (MEF).
For the glucose tolerance test, mice were fasted overnight (14 h)
and injected intraperitoneally with a glucose solution (2 mg/kg).
All experiments in mice were approved by the NYU Institutional
Animal Care and Use Committee.
Cell culture
Trpt1+/+ and Trpt1/ cell lines were obtained by serial passage
of SV40-T-antigen transfected MEFs. The cells were cultured in
DMEM supplemented with 10% Fetal Clone II serum (Hyclone),
and penicillin–streptomycin and glutamine. Extracts were made
from PBS-washed cells collected by scraping and centrifugation
(500g for 5 min) and passage through a ball-bearing homogenizer
(EMBL) after resuspension in four volumes of extract buffer (20 mM
Tris–HCl at pH 7.5, 300 mM KCl, 10 mM MgCl2, 1 mM DTT,
1 mg/mL pepstatin and aprotinin, and 1 mM PMSF) followed by
clearing at 14,000 rpm. For Figure 2B, 2.7 mg of lysate from cells
of each genotype was separated on a 5-mL 10%–30% glycerol
gradient made in extract buffer followed by centrifugation at
40,000 rpm for 12 h in a SW50 rotor.
Substrates and TRPT1 assay
The uridylic acid pentamer (rU5) was synthesized using standard
29-TBDMS phosphoramidite chemistry (Usman et al. 1987). The
rU pentamer containing the internal 29-PO4
2 moiety was
synthesized by the same method except that the monomer 59-O-
(levulinyl)-29-O-(4,49-dimethoxytrityl)uridine 39-O-(2-cyanoethyl-
N,N-diisopropyl) phosphoramidite was introduced at position 3.
Following assembly of the trinucleotide, the cyanoethyl groups
were removed with 2:3 triethylamine/acetonitrile followed by
removal of the 29-DMT group with 3% trichloroacetic acid.
The free 29-OH group was phosphitylated using bis(2-cya-
noethyl)-(N,N-diisopropyl)-phosphoramidite and then oxidized
with I2/water to complete the incorporation of the 29-phosphate
moiety. The growing oligonucleotide was then subjected to a
Ac2O to cap any unreacted 29-OH. The 59-levulinyl group was
removed using hydrazyne hydrate (Lackey et al. 2007) and
oligonucleotide synthesis continued by coupling 29-TBDMS rU
39-amidite monomers. Cleavage of the pentamer from the
support, deprotection, and purification (PAGE) was carried out
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as described by literature procedures (Damha and Ogilvie 1993).
The pentamers were characterized by electron spray (ESI) mass
spectrometry.
The 29-phosphotransferase assay reaction mixes contained
0.2 pm/mL 59-32P-end labeled ribo-oligonucleotide in 20 mM
Tris–HCl at pH 7.5, 5 mM MgCl2, 2.5 mM spermidine, 0.4% Triton
X-100, 100 mM DTT, and 1 mM NAD+, 1 mg of purified bacte-
rially expressed yTpt1p, or the indicated preparation of cell extract.
The 20-mL reactions were incubated at 30°C for 30 min, followed
by phenol–chloroform extraction, precipitation, and separation of
the products on 6 M Urea–25% Acrylamide–TBE gels.
Protein analysis
Trpt1 was detected in heart or MEF cell lysates by immunopre-
cipitation, followed by immunoblotting using previously
described buffers (Harding et al. 2001b) and a polyclonal rabbit
antiserum raised against bacterially expressed and purified mouse
TRPT1 (a kind gift of the Phizicky laboratory). Procedures and
antisera for detecting XBP-1p, CHOP, GADD34, and eIF2 by
direct immunoblotting of nuclear and cytoplasmic lysates have
been previously described (Harding et al. 2001a; Novoa et al.
2001; Calfon et al. 2002). Phosphorylated eIF2a was detected
using the BioSource antibody #44-728G lot #0702.
The translation of XBP-1u, XBP1p, CREB, TLS/FUS, EWS,
TAF15, and eIF2a was measured by pulse-labeling and immuno-
precipitation in Trpt1+/+ and Trpt1/ MEF cell lines. For
[35S]methionine/cysteine metabolic labeling for immunoprecipi-
tation, cells were switched to methionine and cysteine minus
DMEM with 10% dialyzed fetal calf serum 5 min before addition
of -TRAN35S-LABEL (MP Biomedical) at 400 mCi/mL for 60 min.
MG132 (10 mM) was added 5 min before TRAN35S-LABEL where
indicated. For measurement of [35S]methionine/cysteine or 3H
tyrosine incorporation into total proteins (Fig. 4C), cells were
washed in Hanks buffer supplemented with 10% dialyzed fetal calf
serum and 10 mM glucose and then labeled in the same medium
supplemented with 5.5 mCi/mL TRAN35S-LABEL or 3H-tyrosine
(MP Biomedical) for 2 h. Cells were lysed in RIPA, cleared, and
the incorporation of each label into TCA precipitable protein was
measured by scintillation counting.
Statistical analysis
All results are expressed as mean 6 SEM.
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